MedTrace Logo

A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study

NCT01062269 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2011-07-12

Study results available
· View outcomes & findings →

Summary

The purpose of the research study is (1) to rate the taste, texture, appearance, and mixability of 2 different doses of orange flavored cholestyramine compared to orange flavored Tang, (2) rank the importance of the taste, texture, appearance, and mixability when rating cholestyramine and Tang to determine the accuracy and usefulness of a taste test questionnaire.

Conditions

  • Healthy

Interventions

DRUG

Cholestyramine

Cholestyramine 4 grams one time dose

DRUG

Cholestyramine

Cholestyramine 12 grams one dose, one day

DRUG

Tang

Tang one dose one day

Sponsors & Collaborators

  • Provident Clinical Research

    collaborator OTHER

  • Daiichi Sankyo

    collaborator INDUSTRY

  • Louisville Metabolic and Atherosclerosis Research Center

    lead OTHER

Principal Investigators

  • Harold E Bays, MD · L-MARC Research Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-02-28
Completion
2010-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01062269 on ClinicalTrials.gov